SELEXAGEN THERAPEUTICS
Selexagen Therapeutics, Inc. operates as a pharmaceutical company and develops targeted therapies for cancer. The company was incorporated in 2008 and is based in San Diego, California.
SELEXAGEN THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.selexagen.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
597.39 K USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Constant Therapeutics
Constant Therapeutics is a biopharmaceutical company that develops drugs and therapies, with clinical trials for a range of diseases.
Corticrine
Corticrine operates as a pharmaceutical company that develops new therapies for Alzheimer’s dementia.
Ocunexus Therapeutics
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.
Current Advisors List
Current Employees Featured
Founder
More informations about "Selexagen Therapeutics"
Selexagen Therapeutics - Crunchbase Company Profile & Funding
Organization. Selexagen Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Selexagen Therapeutics, Inc. operates as …See details»
Selexagen Therapeutics - PitchBook
Selexagen Therapeutics General Information Description. Developer of therapeutic drugs created to treat cancer. The company's drugs utilizes molecular modeling and structure based drug …See details»
Selexagen Therapeutics - Contacts, Employees, Board Members, …
Selexagen Therapeutics operates as a pharmaceutical company that develops targeted therapies for cancer.See details»
Selexagen - Company Profile - Tracxn
Oct 18, 2024 Selexagen ranks 2,071st among 2364 active competitors. 850 of its competitors are funded while 543 have exited. Overall, Selexagen and its competitors have raised over …See details»
Selexagen Therapeutics - Products, Competitors, Financials, …
Selexagen is biotechnology startup currently in stealth mode. Use the CB Insights Platform to explore Selexagen Therapeutics's full profile. Selexagen Therapeutics - Products, …See details»
Selexagen Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Selexagen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Selexagen Therapeutics - Funding, Financials, Valuation & Investors
Selexagen Therapeutics has raised a total of . $597.4K. in funding over 1 round. This was a Seed round raised on Aug 1, 2011. Unlock for free . Funding Rounds. ... How much funding has this …See details»
Selexagen Therapeutics, Inc.:Company Profile & Technical …
Selexagen Therapeutics, Inc. is a company that provides Health care and more. Selexagen Therapeutics, Inc. is headquartered in United States California. Selexagen Therapeutics, Inc. …See details»
Selexagen - Founders and Board of Directors - Tracxn
Selexagen's founders include Patrick M. O’Connor and Lauren Otsuki.See details»
Selexagen Therapeutics CEO, Founder, Key Executive Team, Board …
Explore {Selexagen Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Patrick M. O'Connor, Ph.D. - Co-Founder, CSO & Board Member
Co-Founder, CSO & Board Member, Selexagen Therapeutics, Inc. San Diego, California, United States. 294 followers 284 connections See your mutual connections. View mutual connections …See details»
Selexagen Therapeutics - Tech Stack, Apps, Patents & Trademarks
Selexagen Therapeutics operates as a pharmaceutical company that develops targeted therapies for cancer.See details»
Ruga Corporation Acquires a Novel B-RAF Paradox Breaker
May 18, 2012 We're very eager to build on the exciting work already completed by Selexagen." Ruga's proprietary technology platform, focused on tumor-selective adaptation responses, …See details»
Ruga Corporation Acquires a Novel B-RAF Paradox Breaker …
May 17, 2012 /PRNewswire/ -- Ruga Corporation, a privately held oncology company focused on the discovery and development of personalized therapeutics targeting...See details»
Ruga Licenses Selexagen’s RAF Kinase Program for Targeted …
May 18, 2012 The RAF kinase licensed in from Selexagen will complement Ruga’s existing pipeline by targeting an additional pathway used by tumor cells to proliferate, adapt, and …See details»
Selexagen Therapeutics - Crunchbase
Selexagen Therapeutics operates as a pharmaceutical company that develops targeted therapies for cancer.See details»
Double-therapy approach effectively inhibited | EurekAlert!
Image: Patrick M. O'Connor, Ph.D., is chief scientific officer of Selexagen Therapeutics and editorial board member for Cancer Research. view more . Credit: Patrick M ...See details»
Research programme: cancer therapeutics - Emerald …
Emerald Biostructures and Selexagen are collaborating to discover and develop therapeutics for the treatment of cancer. Development is at the research stage inSee details»
Patrick O’Connor - CEO @ Actagene Oncology - Crunchbase
In early 2009, Dr. O’Connor co-founded Selexagen Therapeutics, where as Chief Scientific Officer he led the development of a RAF Inhibitor Program that was acquired by Ruga Corporation in …See details»
Great Place to Work® Designates Selexis as a Best Workplace in ...
Geneva, Switzerland, May 11, 2022 – Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work® has designated the Company among the “Best Workplaces …See details»